These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16599849)

  • 1. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens.
    Thrailkill K; Cockrell G; Simpson P; Moreau C; Fowlkes J; Bunn RC
    Clin Chem Lab Med; 2006; 44(4):503-4. PubMed ID: 16599849
    [No Abstract]   [Full Text] [Related]  

  • 2. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.
    Jung K
    Clin Chem Lab Med; 2006; 44(4):500-2. PubMed ID: 16599848
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.
    Thrailkill KM; Moreau CS; Cockrell G; Simpson P; Goel R; North P; Fowlkes JL; Bunn RC
    Clin Chem Lab Med; 2005; 43(12):1392-9. PubMed ID: 16309379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9.
    Jung K; Klotzek S; Stephan C; Mannello F; Lein M
    Clin Chem; 2008 Apr; 54(4):772-3. PubMed ID: 18375496
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of blood collection methods on gelatin zymography of matrix metalloproteinases.
    Mannello F
    Clin Chem; 2003 Feb; 49(2):339-40. PubMed ID: 12560371
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Domysławska I; Chwiećko J
    Przegl Lek; 2005; 62(12):1321-4. PubMed ID: 16786739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in blood from patients with LAM.
    Odajima N; Betsuyaku T; Nasuhara Y; Inoue H; Seyama K; Nishimura M
    Respir Med; 2009 Jan; 103(1):124-9. PubMed ID: 18760908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation.
    Abdallah MA; Nakajima ST; Lin PC; Gercel-Taylor C
    Fertil Steril; 2005 Dec; 84(6):1766-7. PubMed ID: 16359987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
    Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
    Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood.
    Jung K; Lein M; Laube C; Lichtinghagen R
    Clin Chim Acta; 2001 Dec; 314(1-2):241-4. PubMed ID: 11718702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
    Kuropkat C; Duenne AA; Herz U; Renz H; Werner JA
    Neoplasma; 2004; 51(5):375-8. PubMed ID: 15640942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 May; 13(4):561-2. PubMed ID: 17463079
    [No Abstract]   [Full Text] [Related]  

  • 19. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.